Form 4: PetMed Express CAO Awarded 10,000 Restricted Shares

PetMed Express's Chief Accounting Officer, Douglas Krulik, received a grant of 10,000 restricted common shares, vesting in six months.

Summary

• Douglas Krulik, Chief Accounting Officer of PetMed Express Inc. (PETS), was granted 10,000 shares of common stock.
• The transaction occurred on September 9, 2025, and was an acquisition (A) of securities.
• The shares were acquired at a price of $0, indicating a restricted stock award.
• Following this transaction, Mr. Krulik beneficially owns 50,000 shares of common stock.
• The award is granted under the PetMed Express, Inc. 2024 Omnibus Incentive Plan.
• The restricted stock award will vest in its entirety on the 6-month anniversary of the grant date, provided Mr. Krulik remains employed or in service with the Company.
• Full vesting will also occur if the Company terminates Mr. Krulik's service prior to full vesting, unless the termination is for Cause.

Sentiment

Score: 6

Explanation: The filing reports a routine executive compensation event. It's mildly positive as it aligns management interests with shareholders and aids retention, but it's not a significant market-moving event.

Positives

• The restricted stock award aligns the Chief Accounting Officer's interests with those of shareholders, incentivizing long-term performance.
• This grant serves as a retention mechanism for key management personnel, ensuring continuity in leadership.
• The award is part of a structured incentive plan (2024 Omnibus Incentive Plan), indicating a formal approach to executive compensation.

Negatives

• The issuance of 10,000 new shares, while minor, represents a slight dilution for existing shareholders.

Risks

• The restricted stock award is subject to forfeiture if Mr. Krulik's employment or service with the Company is terminated for 'Cause' (as defined in the 2024 Omnibus Plan) prior to the full vesting date.

Future Outlook

The restricted stock award is designed to vest on the 6-month anniversary of the grant date, contingent on the Chief Accounting Officer's continued service, or in the event of termination without cause. This structure aims to incentivize future performance and retention.

Industry Context

The granting of restricted stock awards to key executives is a common practice in publicly traded companies across various industries, including the pet care and e-commerce sectors. It is a standard component of executive compensation packages designed to align management incentives with shareholder value creation and to promote long-term retention.

Comparison to Industry Standards

• The use of restricted stock awards with time-based vesting is a widely accepted and standard practice for executive compensation in the U.S. market, comparable to practices at companies like Chewy (CHWY) or Zoetis (ZTS) for retaining key talent.
• The vesting period of six months is relatively short compared to typical multi-year vesting schedules (e.g., 3-5 years) often seen for long-term incentive plans, which might suggest a specific retention or performance objective for this particular grant.

Corporate Governance

Stakeholder Impact

• Shareholders: Experience minor dilution from the issuance of new shares, but benefit from increased alignment of executive incentives with long-term company performance.
• Employees: The grant to a key executive may set a precedent or signal the company's approach to rewarding and retaining senior talent.

Next Steps

• The restricted stock award is expected to vest on the 6-month anniversary of the grant date (approximately March 9, 2026), subject to the stated conditions.

Key Dates

Keywords

PetMed Express, PETS, Douglas Krulik, Chief Accounting Officer, Restricted Stock Award, Executive Compensation, Insider Transaction, Form 4, Omnibus Incentive Plan